Study to Evaluate the Safety and Concentrations of Monoclonal Antibody Against Virus That Causes COVID-19 Disease.
Condition(s):COVID-19 Virus DiseaseLast Updated:April 27, 2022Completed
Hide Studies Not Open or Pending
Condition(s):COVID-19 Virus DiseaseLast Updated:April 27, 2022Completed
Condition(s):Peripheral T Cell LymphomaLast Updated:March 18, 2024Completed
Condition(s):Tolerability, Safety, Immunogenicity and Pharmacokinetic of JS005Last Updated:January 7, 2020Unknown status
Condition(s):Non-Hodgkin Lymphoma, B-cellLast Updated:August 23, 2023Not yet recruiting
Condition(s):AdenocarcinomaLast Updated:June 24, 2005Completed
Condition(s):Acute GoutLast Updated:October 20, 2022Recruiting
Condition(s):Breast CancerLast Updated:February 10, 2022Completed
Condition(s):Hepatocellular CarcinomaLast Updated:April 19, 2023Recruiting
Condition(s):Cancer; Neoplasm MetastasisLast Updated:February 5, 2010Completed
Condition(s):Advanced Cancer; Angiosarcoma; Colorectal Cancer Without Liver Metastases; Endometrial Cancer; Fibrolamellar Carcinoma; Non-small-cell Lung Cancer; Ovarian Cancer; Prostate CancerLast Updated:November 13, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.